![Samantha Haeberlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samantha Haeberlein
Directeur/Membre du Conseil chez
The Boston Home
Profil
Samantha Budd Haeberlein is currently Director at The Boston Home and Senior Advisor at Intermediate Capital Group Plc (Private Equity) since 2023.
Formerly, Dr. Haeberlein was Independent Director at Vigil Neuroscience, Inc. from 2023 to 2025, Director at Rodin Therapeutics, Inc. in 2016, Vice President-Clinical Development at Biogen, Inc. from 2015 to 2020, Vice President & Head-Translational Science at AstraZeneca LP from 2012 to 2015, and Director at Stockholm Brain Institute from 2007 to 2011.
Education includes undergraduate and doctorate degrees from the University of Dundee.
Postes actifs de Samantha Haeberlein
| Sociétés | Poste | Début |
|---|---|---|
The Boston Home
 The Boston Home Medical/Nursing ServicesHealth Services Operates as a non profit organization that provides care residence services for adults | Directeur/Membre du Conseil | - |
Intermediate Capital Group Plc (Private Equity)
 Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance ICG invests in companies located across the globe, primarily in Asia-Pacific, Western Europe and North America. The firm focuses across a broad range of sectors and industries. It provides financing in the form of mezzanine, debt and equity for real estate, infrastructure, secondary and buyout capital requirements. The firm acquires minority and control interest. | Consultant / Advisor | 01/09/2023 |
Anciens postes connus de Samantha Haeberlein
| Sociétés | Poste | Fin |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Directeur/Membre du Conseil | 05/08/2025 |
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2020 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Directeur/Membre du Conseil | 01/12/2016 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 01/01/2015 |
Stockholm Brain Institute | Directeur/Membre du Conseil | 01/01/2011 |
Formation de Samantha Haeberlein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intermediate Capital Group Plc (Private Equity)
Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance ICG invests in companies located across the globe, primarily in Asia-Pacific, Western Europe and North America. The firm focuses across a broad range of sectors and industries. It provides financing in the form of mezzanine, debt and equity for real estate, infrastructure, secondary and buyout capital requirements. The firm acquires minority and control interest. | Finance |
The Boston Home
The Boston Home Medical/Nursing ServicesHealth Services Operates as a non profit organization that provides care residence services for adults | Health Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Stockholm Brain Institute | |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
